Ming Liu

Ming Liu has a diverse and extensive work experience in the field of science and research. Since 2021, Ming Liu has been serving as the President of Unity Sciences. Prior to this, Ming Liu held important roles at ChemPartner, starting as the Vice President of Biology and Pharmacology in 2018 and eventually becoming the Senior Vice President in 2020. Ming Liu also has experience as the President and Project Director at Unity Sciences/Biogenesis Bago S.A. from 2012 onwards. Earlier in their career, Ming Liu worked as an Associate Director at Merck Research Laboratories from 2009 to 2011 and held various positions at Schering-Plough Research Institute, including Associate Director, Section Leader, Principal Scientist, Associate Principal Scientist, and Senior Scientist. Overall, Ming Liu's work experience demonstrates leadership, expertise, and a strong track record in the pharmaceutical and biotechnology sectors.

Ming Liu completed their education in a chronological order. They first attended National Taiwan University from 1975 to 1980, where they earned a degree in Veterinary Medicine. Following this, they pursued a Ph.D. in Molecular Virology at Baylor College of Medicine from 1984 to 1990. Their most recent educational endeavor was at Harvard Medical School, where they completed Post Doctoral Training in the field of Oncology from 1990 to 1993.